Drugs / adipose tissue derived stromal cells
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00913289 | Feb 2009 → Apr 2010 | cirrhosis of liver | Kanazawa University | Terminated | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT01062750 | Oct 2012 → Feb 2015 | cirrhosis of liver | Kanazawa University | Completed | No outcome recorded |
| — | NCT01709279 | Aug 2012 → Aug 2019 | heart failure | Kanazawa University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adipose tissue derived stromal cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00913289 ↗ |
| Modality | Cell therapy | “autologous adipose tissue derived stromal cells” NCT00913289 ↗ |
| Route | Other | “via intrahepatic arterial catheterization” NCT01062750 ↗ |